pyridostigmine bromide has been researched along with Autoimmune Diabetes in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bharucha, AE; Burton, D; Camilleri, M; Gehrking, T; Kudva, Y; Low, P; Shah, P; Veil, E; Zinsmeister, AR | 1 |
| Lennon, VA; Lunsford, TN; Pasha, SF | 1 |
| Andler, W | 1 |
| Ismail, IS; Miell, JP; Peters, JR; Scanlon, MF | 1 |
| Ismail, IS; Peters, JR; Scanlon, MF | 1 |
| Bodini, C; Bossoni, S; Giustina, A; Valentini, U; Wehrenberg, WB | 1 |
| Arvat, E; Bertaina, S; Bruno, G; Camanni, F; Ghigo, E; Maccario, M; Martina, V; Tagliabue, M; Zumpano, E | 1 |
| Giustina, A; Ndon, JA; Wehrenberg, WB | 1 |
| Bodini, C; Bossoni, S; Cimino, A; Giustina, A; Pizzocolo, G; Schettino, M; Wehrenberg, WB | 1 |
| Bossoni, S; Cimino, A; Giustina, A; Pizzocolo, G; Romanelli, G; Wehrenberg, WB | 1 |
6 trial(s) available for pyridostigmine bromide and Autoimmune Diabetes
| Article | Year |
|---|---|
A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Algorithms; Cholinesterase Inhibitors; Constipation; Defecation; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Male; Middle Aged; Pyridostigmine Bromide; Treatment Outcome | 2013 |
Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
Topics: Blood Glucose; Carrier Proteins; Diabetes Mellitus, Type 1; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Male; Pirenzepine; Pyridostigmine Bromide; Stimulation, Chemical; Time Factors | 1995 |
Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
Topics: Adult; Blood Glucose; Cholinesterase Inhibitors; Diabetes Mellitus, Type 1; Feedback; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamus; Male; Middle Aged; Pirenzepine; Pyridostigmine Bromide; Somatostatin | 1993 |
Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Female; Growth Hormone; Humans; Individuality; Male; Pyridostigmine Bromide; Single-Blind Method | 1993 |
Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.
Topics: Administration, Oral; Adolescent; Adult; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Injections, Intravenous; Male; Middle Aged; Pyridostigmine Bromide | 1991 |
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
Topics: Adolescent; Adult; Cholinesterase Inhibitors; Diabetes Mellitus, Type 1; Drug Synergism; Female; Glycated Hemoglobin; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Kinetics; Male; Pyridostigmine Bromide | 1990 |
4 other study(ies) available for pyridostigmine bromide and Autoimmune Diabetes
| Article | Year |
|---|---|
Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine.
Topics: Autoantibodies; Autoimmune Diseases; Autonomic Nervous System Diseases; Cholinesterase Inhibitors; Diabetes Mellitus, Type 1; Female; Gastrointestinal Motility; Humans; Middle Aged; Pyridostigmine Bromide | 2006 |
Myasthenia gravis, primary adrenocortical insufficiency, and juvenile diabetes mellitus in a twelve-year-old boy.
Topics: Adrenal Insufficiency; Child; Diabetes Mellitus, Type 1; Fludrocortisone; Humans; Hydrocortisone; Insulin; Male; Myasthenia Gravis; Pyridostigmine Bromide | 1983 |
Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Male; Pyridostigmine Bromide; Reference Values | 1997 |
Hypothalamic regulation of impaired growth hormone secretion in diabetic rats. 2. Studies in spontaneously diabetic BB Worcester rats.
Topics: Animals; Antibodies; Cholinesterase Inhibitors; Diabetes Mellitus, Type 1; Growth Hormone; Growth Hormone-Releasing Hormone; Hypothalamus; Kinetics; Pyridostigmine Bromide; Rats; Rats, Inbred BB; Somatostatin | 1992 |